In this review we will mainly discuss ErbB2-induced invasion in the context of breast cancer, as ErbB2 function is most extensively studied in breast cancer, where its aberrant overexpression and activation is strongly linked to an invasive, aggressive phenotype and poor prognosis [12,13]. Here, ERBB2 is linked to breast carcinoma.